| HS Code | 563373 |
| Product Name | Sodium Dimercaptopropanesulfonate Veterinary Grade API |
| Chemical Formula | C3H6NaO3S2 |
| Molecular Weight | 180.20 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Highly soluble in water |
| Intended Use | Active pharmaceutical ingredient for veterinary medicines |
| Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Storage Conditions | Store in a cool, dry place away from light |
| Purity | ≥98% (by HPLC) |
| Cas Number | 1777-49-3 |
As an accredited Sodium Dimercaptopropanesulfonate Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in 25 kg fiber drums with double-layer polyethylene bags, clearly labeled for veterinary use and production batch information. |
| Shipping | The Sodium Dimercaptopropanesulfonate Veterinary Grade API is securely packaged in sealed, moisture-resistant containers, typically fiber drums or HDPE bags, and shipped in compliance with international regulations for chemical safety. Each batch includes proper labeling, documentation (COA, MSDS), and temperature-controlled transport as required, ensuring product integrity during transit for all dosage forms. |
| Storage | Sodium Dimercaptopropanesulfonate Veterinary Grade API should be stored in a tightly sealed container, protected from light, moisture, and extreme temperatures. Keep in a cool, dry, and well-ventilated area, preferably at room temperature (15-25°C). Store away from incompatible substances and ensure the storage area conforms to pharmaceutical standards for handling active pharmaceutical ingredients. Keep out of reach of unauthorized personnel. |
Competitive Sodium Dimercaptopropanesulfonate Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618136850665
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Sodium dimercaptopropanesulfonate, often called DMPS, demands attention to detail at every step in the plant. Crafting the veterinary grade goes beyond chemical synthesis. Precision matters most in controlling the reaction—keeping the right temperature range, ensuring purity of the sodium hydroxide and mercaptopropanesulfonic acid, and crafting an end product that meets stringent physical and chemical markers. Over the years in our production areas, we’ve learned batch consistency separates a passable ingredient from one a veterinarian can depend on. If crystals show the wrong hue, or a batch has a trace of excess sodium salt, rework or rejection follows. There’s simply nothing routine about API production; it’s a hands-on process where experience and vigilance guide every improvement.
Our veterinary API originates from strict standardization, not only for DMPS content but for other markers too. Model distinctions—like fine crystalline powder or granular concentrate—spring from real demand. In our manufacturing runs, powder grade DMPS heads for solvent-based injectable solutions because it shows easy solubility and leaves no sediment. Granular DMPS, on the other hand, moves into direct tableting lines and premixes for feedmills, because it handles automated dispensing and mixing with fewer dust concerns. Specifications such as assay, moisture, and bulk density see continuous refinement based on feedback from formulating partners. Strict thresholds for heavy metals, microbial count, and pH form part of every release certificate, not just to pass regulatory screens, but because contaminated chemicals jeopardize both animal and end user safety.
Most people in the plant rarely see the end goals that drive veterinary suppliers: supporting livestock, companion animals, and specialized cases like wildlife recovery. We take pride in knowing DMPS runs through complex bottling lines destined for emergency chelation kits in vet clinics. In practice, injectable DMPS enters the world’s veterinary market for poisoning cases—helping remove heavy metals from the animal body. Tablet and capsule forms address long-term maintenance in chronic or environmental-exposure cases. DMPS granules and premix grades head for premixing stations at feedmills that cater to bird, swine, and large animal producers working to protect their herds from toxin exposure. Each grade solves a real-world problem for veterinarians; this perspective grounds every batch decision at the production scale.
DMPS’s structure gives it unique chelating power through its dual thiol groups, allowing for complexation of lead, mercury, and arsenic. Other veterinary APIs, such as dimercaprol or DMSA, can also chelate metals, but the water solubility and manageable safety profile of DMPS push it ahead for veterinary applications. Older chelators like dimercaprol require oily vehicles, raising challenges in formulating for livestock or small animals. DMSA sees use mostly for human cases, and its higher cost and availability limit its wider use in feed and farm situations. In our experience, the vet market values the lower toxicity profile that DMPS brings, which opens up its use for broader ranges of animal sizes, from birds to cattle. Also, our direct feedback from formulators—those operating high-speed tableting lines or aqueous injectables—rarely fail to mention the flow and dissolution characteristics we build into our product.
At the chemical reactor and in the blending room, small tweaks produce large impacts. API markets punish those who skip these details. Our work has shown that DMPS, if not fully dried or processed with the wrong grade of inert carrier, will clump or form hard lumps when mixed into tablet blends or premix. Excess fines create handling hazards, dusting, and can even trigger downtime for automated equipment. Learning from this, our team dials particle size distributions to suit each customer's process. Maintaining strict controls on residual solvents keeps our material clean, and high-purity water for the final washes ensures no leftover impurities ride with the API into the animal’s body. Anyone who has handled a batch with suboptimal drying knows the headaches: sticky powders, jammed hoppers, and inconsistent dosing. These practical headaches fuel our constant improvements, more than any theoretical improvement could.
Practically every market receiving our DMPS carries its own regulatory nuances. Some importers chase GMP certifications, others build their oversight around VMP (Veterinary Medicinal Product) frameworks, and still others reference country-level compendia. Meeting these differences means we actively review compliance feedback and routinely challenge our own test results. Any failed test—for identity, purity, or residual solvents—halts shipment and kicks off a corrective action investigation. The process is tough, but after years spent on the regulatory treadmill, our team’s confidence in the batch is built on real and repeated audit success. Every improvement positions our product on firmer footing in both established and emerging export markets.
Technical teams from our customer base come to us with more than price requests; they bring real-world headaches from the field. Many tableting operations run into sticking, capping, or flow failures unless the DMPS input meets strict particle size and moisture markers. Poorly flowing powder can toss weight variance outside tolerance and escalate rejection rates. Our R&D works directly with their line supervisors, running trial batches and varying grind parameters or moisture cuts. Over repeated cycles, we have reduced the need for added glidants and minimized loss in final blends, raising yield for finished veterinary drug products. Our solution-driven partnership with feed premixers came from fielding complaints on lumping and inconsistent dissolution. We returned with a modified granule—less prone to static and easier to incorporate—leading to cleaner blending and higher final product quality. These interactions shape our product development roadmap more strongly than theoretical market forecasts.
Every run of DMPS for veterinary API comes assigned a unique process number, enabling tracing from raw material batch through to the bag in the customer’s hands. Production staff record all source materials, production times, and all critical process parameters in real time. More than a paperwork exercise, we’ve faced real recall scenarios that tested these systems. Quick retrieval of batch logs, coupled with retained samples from every production run, allowed investigations and responses within days rather than weeks. Feedback loops from field complaints—such as unexpected odor, color change, or clumping—trigger deep dive analyses. We see our traceability system as a shield for our customers’ reputation; it gives us the agility to address emerging issues, and our trace file has withstood regulatory review under real stress. Transparency here doesn’t grow from pressure—it’s the byproduct of experience and the challenges faced over years in the plant.
Improvements in yield, waste reduction, and reliability don’t appear overnight. Early production learning curves meant batches lost to suboptimal temperature ramps or pH settings. Small process measurements—such as optimizing addition rates for sodium hydroxide or tuning reaction time—yield stronger, more stable products. Use of analytical sampling during reactions, not just at the end, lets team leaders spot off-spec trends before they become critical. Automation helps, but the seasoned eye of an operator often spots process drift faster than any software alert. Bringing in feedback from machine operators, not just laboratory staff, reveals where real-life inefficiencies leak away productivity. Meanwhile, investment in higher-grade reaction vessels and dust-controlled transfer lines keeps maintenance down and improves overall product cleanliness. These investments grow from practical lessons, not spreadsheet projections.
Relationships with veterinary clients move far beyond the screenshot of a certificate of analysis. Recent cases have highlighted how flexible shipping and rapid technical response can make or break a crisis response—especially for animal poisoning outbreaks. We’ve been able to turn around lots or adjust output schedules to meet urgent requests. Veterinary supply chains sometimes require pivots: changing planned packaging formats, reconfiguring granule size, or easing air-freight. From direct dialogue with veterinary pharmacists, we’ve adapted both packaging and labelling to fit field use in a variety of climates—a direct result of hearing about product caking in tropical humidity or staling in dry camps. This adjustment involved real cost and real effort, but removed recurring complaints. There’s value in knowing our product does not just pass the lab’s test but survives the journey to the animal that needs it—especially in remote or resource-strained regions.
DMPS production produces waste streams that demand care—mostly water-based but also containing sulfur compounds traceable to our plant site. Years back, releases into the effluent tank taught us a tough lesson on proper neutralization and filtration before discharge. Such incidents triggered upgrades in waste management—installing upgraded neutralizers, scrubbers and routine third-party testing. Shifting to closed-loop water systems cut the plant’s demand for fresh water. At the packaging end, we moved toward recyclable sacks and are piloting a return program for bulk packaging with some partners. The environmental costs of production once lurked in the background. Direct exposure and learning moved them to the front lines for our production managers. Today, every operator ties his or her hands-on work directly to environmental benchmarks, not by distant mandate but by experience earned on the shop floor.
DMPS faces recurring raw material bottlenecks, especially for starting materials like mercaptopropanesulfonic acid. Disruption in global supply chains, whether political or environmental, caused costly delays in the past. Our response relied on qualifying multiple suppliers within a reasonable radius and holding buffer stocks at key points of the production calendar. During heavy demand spikes, this buffer system let us continue shipping when competitors stalled, protecting our customers from shutdown risk. The company learned the hard way that embedded knowledge in logistics and procurement sets as much of the customer experience as the chemistry does. Regular stress testing of supplier networks and audit of alternative routes became routine.
API manufacturers previously kept their walls up: the product left the gate, and responsibility stopped. Through repeated collaboration with animal health providers, toxicology researchers, and global NGOs tasked with protecting livestock and wildlife, the attitude has shifted. Participation in ongoing research has returned benefits to both sides. Techniques for faster chelation, improved dosing regimens, and better tolerance in delicate animals have flowed from real field trial feedback. We’ve donated lots for field trials during heavy metal poisoning outbreaks, which in turn improved our practices and reinforced our commitment to the sector. These partnerships brought home how a seemingly minor input change can upgrade veterinary care at the farm or rescue center.
Feedback loops start at the factory wall but extend far. Veterinarians and feed mill technicians have given us insights lost at the bench scale: how poor flow ends up halting high-speed tableting, how minor odor variation transfers into field complaints by stockmen handling premixes daily. Farmers on the receiving end saw the result of inconsistent granulation as inconsistent animal health benefits. Direct dialogue at industry expos and regular plant visits with customers led us to rethink old assumptions about what constitutes an acceptable batch. For instance, improvements in bulk density enabled more accurate feed blending, reducing overdosing risks in the field. Often these improvements grow less out of formal complaints and more from spontaneous comments by users who depend on consistent performance day-in, day-out.
API buyers, especially in veterinary applications, don’t trust claims resting solely on a polished datasheet. Brand strength comes from the cumulative reputation earned on the ground. Every delayed shipment, failed batch, or subpar product echoes through the supply chain faster than marketing can account for. Over the years, we’ve seen that solving supply problems promptly, resolving complaint investigations transparently, and sending technical staff to troubleshoot issues on-site shape the market’s trust. Our best customer advocates are those that see us standing with them through problem-solving, not just pushing product in bulk.
Manufacturing sodium dimercaptopropanesulfonate for the veterinary market is more than an exercise in compliance or precision chemistry. The value rests on the daily discipline of listening to those that rely on this API, and refining not just the chemical process but the final, real-world application. Every challenge in production—be it raw material fluctuations, handling headaches in tableting, or changing demands from the regulatory sector—translates into a lesson that strengthens the next batch, the next partnership, and the next delivery to the field. Through the continuous improvement driven by feedback and the practical goals of animal health, we strive to keep our veterinary DMPS API as a trusted solution across clinics, farms, and feedmills world over.